No Data
Institutional Investors Have a Lot Riding on Teva Pharmaceutical Industries Limited (NYSE:TEVA) With 68% Ownership
Nvidia To Rally Around 31%? Here Are 10 Top Analyst Forecasts For Friday
Novo Nordisk's Ozempic, Wegovy Among Drugs Chosen for US Medicare Price Talks
'Ozempic Is In The Next Round Of Medicare Drug Price Negotiations. See The Full List Of 15 Medications' - CNBC
Pre-market drop of over 4%! Novo-Nordisk A/S's "weight loss miracle drug" enters price negotiations with USA healthcare.
The diabetes drug Ozempic and the weight loss drug Wegovy, among 15 other medications from Novo-Nordisk A/S, have been included in the USA government’s plan for Medicare price negotiations scheduled for 2027. After this announcement, Novo-Nordisk A/S's stock price was surpassed by LVMH, making it the second largest publicly traded company in Europe.
Gabapentin Market Trends Report 2025-2030, With Key Competitor Analysis for Sun Pharmaceutical Industries, Ascend Laboratories, Apotex, Teva Pharmaceutical Industries, Arbor Pharmaceuticals and Pfizer